Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

p.i.e. pharma ltd - cyanocobalamin - oral tablet - 50microgram

Lielbritānija - angļu - MHRA (Medicines & Healthcare Products Regulatory Agency)

advanz pharma - ibuprofen - cutaneous gel - 100mg/1gram

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - trifluoperazine hydrochloride 1.18mg equivalent to 1 mg trifluoperazine;   - film coated tablet - 1 mg - active: trifluoperazine hydrochloride 1.18mg equivalent to 1 mg trifluoperazine   excipient: calcium sulfate dihydrate gelatin maize starch opadry blue oy-4492 purified talc purified water as solvent stearic acid sucrose - chronic therapy in high doses for management of manifestations of psychotic disorders, such as acute and chronic catatonic hebephrenic and paranoid schizophrenia, psychosis due to organic brain damage, toxic psychosis, manic depressive psychosis, senile psychosis and mental deficiency. short-term therapy treatment of acute alcoholism for the relief of delusons, hallucinations and confused state, and for the control of accompanying tremulousness and aggressive behaviour. in low doses to control excessive anxiety, tension and agitation as seen in neuroses or associated with somatic conditions. stelazine is not recommended as first line therapy in patients with non-psychotic anxiety disorders, nor should therapy be carried out for more than 12 weeks. for nausea and vomiting of various causes.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - trifluoperazine hydrochloride 2.36mg equivalent to 2 mg trifluoperazine;   - film coated tablet - 2 mg - active: trifluoperazine hydrochloride 2.36mg equivalent to 2 mg trifluoperazine   excipient: calcium sulfate dihydrate gelatin maize starch opadry blue oy-4492 purified talc purified water as solvent stearic acid sucrose - chronic therapy in high doses for management of manifestations of psychotic disorders, such as acute and chronic catatonic hebephrenic and paranoid schizophrenia, psychosis due to organic brain damage, toxic psychosis, manic depressive psychosis, senile psychosis and mental deficiency. short-term therapy treatment of acute alcoholism for the relief of delusons, hallucinations and confused state, and for the control of accompanying tremulousness and aggressive behaviour. in low doses to control excessive anxiety, tension and agitation as seen in neuroses or associated with somatic conditions. stelazine is not recommended as first line therapy in patients with non-psychotic anxiety disorders, nor should therapy be carried out for more than 12 weeks. for nausea and vomiting of various causes.

Jaunzēlande - angļu - Medsafe (Medicines Safety Authority)

boucher & muir (nz) ltd t/a mercury pharma (nz) - trifluoperazine hydrochloride 5.9mg equivalent to 5 mg trifluoperazine;   - film coated tablet - 5 mg - active: trifluoperazine hydrochloride 5.9mg equivalent to 5 mg trifluoperazine   excipient: calcium sulfate dihydrate gelatin maize starch opadry blue oy-4492 purified talc purified water as solvent stearic acid sucrose - chronic therapy in high doses for management of manifestations of psychotic disorders, such as acute and chronic catatonic hebephrenic and paranoid schizophrenia, psychosis due to organic brain damage, toxic psychosis, manic depressive psychosis, senile psychosis and mental deficiency. short-term therapy treatment of acute alcoholism for the relief of delusons, hallucinations and confused state, and for the control of accompanying tremulousness and aggressive behaviour. in low doses to control excessive anxiety, tension and agitation as seen in neuroses or associated with somatic conditions. stelazine is not recommended as first line therapy in patients with non-psychotic anxiety disorders, nor should therapy be carried out for more than 12 weeks. for nausea and vomiting of various causes.

Īrija - angļu - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - nitrofurantoin - capsule, hard - 100 milligram(s) - nitrofuran derivatives; nitrofurantoin

Īrija - angļu - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - nitrofurantoin - capsule, hard - 50 milligram(s) - nitrofuran derivatives; nitrofurantoin

Malta - angļu - Malta Medicines Authority

mercury pharmaceuticals limited - levothyroxine sodium - tablet - levothyroxine sodium 25 µg - thyroid therapy

Īrija - angļu - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - trifluoperazine - film-coated tablet - 1 milligram(s) - phenothiazines with piperazine structure; trifluoperazine

Īrija - angļu - HPRA (Health Products Regulatory Authority)

mercury pharmaceuticals ltd - trifluoperazine - film-coated tablet - 5 milligram(s) - phenothiazines with piperazine structure; trifluoperazine